Lymphoma

Non-Hodgkin's lymphoma (NHL) is a type of cancer of the lymphatic system. In rare cases, NHL remains in one specific place in the body. For example, they can go to the bone marrow, liver, and central nervous system. That is why they are called systemic malignant diseases.

Hodgkin's lymphoma is a cancer of the cells of the lymphatic system. In most cases, the disease affects the lymph nodes in certain parts of the body (neck, chest and abdominal cavities, groin and axillary regions). Practice shows that this type of oncology is treatable.

Risk factors

The cause of most cases of non-Hodgkin's lymphoma is unknown. However, there are a number of factors that can trigger lymph cancer:

  • weakened immune system;
  • abdominal diseases;
  • Epstein-Barr virus infection.

Symptoms

The main symptom of the disease is swollen lymph nodes in the neck, groin and armpits. Other symptoms include:
  • excessive sweating, especially at night;
  • unexplained high fever;
  • weight loss;
  • fast fatiguability;
  • shortness of breath and cough;
  • whole body itching.

Diagnostics

Before starting treatment for lymph node cancer, it is necessary to determine the type of disease. An accurate diagnosis can only be made with a lymph node biopsy followed by an immunohistochemical study for the presence or absence of cells in the body called Sternberg-Reed (malignant B-lymphocytes). Some people have a special type of non-Hodgin lymphoma. At the beginning of the chemotherapy course, they are prescribed a lumbar puncture procedure, the purpose of which is to find out if there are malignant cells in the cerebrospinal fluid.

Treatment

The choice of treatment depends on the stage and type of lymphoma.

Poorly differentiated types of lymphomas develop rather slowly, sometimes patients only need regular examinations, and treatment is postponed for a long time. These lymphomas are treated with chemotherapy and radiation therapy.

Highly differentiated types of lymphomas develop rapidly and require intensive chemotherapy with monoclonal antibodies. In this case, there is a threat of damage to the nervous system, so a drug is sometimes injected into the area near the spinal cord (intrathecal chemotherapy). If symptoms reappear, high-dose chemotherapy and radiation therapy may be prescribed.

Service record



Specialists

All specialists
Merkulov
Igor Alexandrovich

Deputy chief physician for oncology, oncologist

Doctor of Sciences, PhD


Academician, professor, Doctor of Sciences, PhD

Petrov
Dmitry Yurevich

Deputy chief physician for oncology, surgeon

PhD, Docent

Ershova
Ksenia Igorevna

Head of department, oncologist

PhD

Rasner
Pavel Ilyich

Consultant in urology, urologist

Doctor of Sciences, PhD, professor

Malygin
Sergey Evgenyevich

Oncologist-mammologist, surgeon

Pshikhachev
Ahmed Mukhamedovich

Urologist, Oncologist

Doctor of Sciences, PhD

Shevchuk
Alexei Sergeyevich

Oncogynecology consultant, obstetrician-gynecologist

PhD

Chichkanova
Tatyana Vladimirovna

Oncologist-mammologist, radiologist

Katz
Ksenia Vladimirovna

Dermatovenerologist, oncologist

Rakova
Elena Sergeevna

Oncologist, chemotherapist

Udin
Oleg Ivanovich

Deputy chief physician for surgery, surgeon

PhD

Kogonia
Lali Mikhailovna

Chemotherapist

Doctor of Sciences, PhD

Ushenina
Maria Valerievna

Oncologist-chemotherapist

PhD

Stepura
Yulia Evgenievna

Head of the department of antitumor drug therapy, oncologist, chemotherapist

Volkova
Daria Mikhailovna

Head of the radiation therapy department

Gomov
Mikhail Alexandrovich

Consultant in oncogynecology, obstetrician-gynecologist

Grishin
Igor Igorevich

Obstetrician-gynecologist

Doctor of Sciences, PhD, professor

Achba
Maya Otarovna

Radiologist, ultrasound diagnostician, oncologist-mammologist